Neurology

Webinar 3: The Future of Epilepsy: From Big Data to Individualized Precision Therapy

This course provides an in-depth exploration of advancements in epilepsy care, focusing on the intersection of genetics, precision therapies, and emerging technologies. Participants will gain a comprehensive understanding of the role of single-gene mutations and polygenic risk scores in shaping treatment strategies. The course also examines the application of precision therapies in personalized care and the transformative potential of AI, machine learning, and big data in seizure detection and management. Additionally, future innovations in epilepsy surgery and wearable technology are discussed, highlighting their contributions to improving precision and treatment outcomes.

DURATION

1 hr

PROFESSION

Specialist

# OF CREDITS

1

ACCREDITATION

MOC - Section 1

EXPIRY DATE

2025-11-27

This course provides an in-depth exploration of advancements in epilepsy care, focusing on the intersection of genetics, precision therapies, and emerging technologies. Participants will gain a comprehensive understanding of the role of single-gene mutations and polygenic risk scores in shaping treatment strategies. The course also examines the application of precision therapies in personalized care and the transformative potential of AI, machine learning, and big data in seizure detection and management. Additionally, future innovations in epilepsy surgery and wearable technology are discussed, highlighting their contributions to improving precision and treatment outcomes.


This program has received an unrestricted educational grant or in-kind support from Paladin Pharma Inc.

Faculty

Moderator:
Esther Bui, MD, FRCPC

Panelist:
Danielle Andrade, MD, MSc, FRCPC, CSCN (EEG)

Learning objectives

After completion of the webinar participants will be better able to:

  1. Understand the genetics of epilepsy, including single-gene mutations and polygenic risk scores, and their effects on treatment
  2. Evaluate precision therapies in epilepsy management and their role in personalized care
  3. Investigate the role of AI, machine learning, and big data in seizure detection and advancing epilepsy care
  4. Discuss future innovations in epilepsy surgery and wearable technology that improve precision and treatment outcomes

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of General Surgeons. You may claim a maximum of 1 hour per webinar.

Cost of course:  
Free
# of credits: 1
Duration: 1 hr

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

Webinar 3: The Future of Epilepsy: From Big Data to Individualized Precision Therapy

1 hr

Duration

Specialist

Profession

1

# of credits

Learning Objectives

After completion of the webinar participants will be better able to:

  1. Understand the genetics of epilepsy, including single-gene mutations and polygenic risk scores, and their effects on treatment
  2. Evaluate precision therapies in epilepsy management and their role in personalized care
  3. Investigate the role of AI, machine learning, and big data in seizure detection and advancing epilepsy care
  4. Discuss future innovations in epilepsy surgery and wearable technology that improve precision and treatment outcomes

MOC - Section 1

ACCREDITATION

Neurology

Learning Category

Epilepsy

Topic

0

Price

2025-11-27

Expiry Date

CAN-eng

Region/Language

Course Description

This course provides an in-depth exploration of advancements in epilepsy care, focusing on the intersection of genetics, precision therapies, and emerging technologies. Participants will gain a comprehensive understanding of the role of single-gene mutations and polygenic risk scores in shaping treatment strategies. The course also examines the application of precision therapies in personalized care and the transformative potential of AI, machine learning, and big data in seizure detection and management. Additionally, future innovations in epilepsy surgery and wearable technology are discussed, highlighting their contributions to improving precision and treatment outcomes.


This program has received an unrestricted educational grant or in-kind support from Paladin Pharma Inc.

Faculty

Moderator:
Esther Bui, MD, FRCPC

Panelist:
Danielle Andrade, MD, MSc, FRCPC, CSCN (EEG)

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of General Surgeons. You may claim a maximum of 1 hour per webinar.